Our prevalence of truncal acne (63.6%, including both truncal-only and combined facial-truncal disease) exceeds previous reports of approximately 50%. The presence of truncal involvement in addition to facial acne was associated with significantly greater health-related quality-of-life impairment compared with facial acne alone. These findings highlight the need for proactive assessment of truncal acne lesions and guideline recommendations addressing truncal acne. Improved recognition and tailored treatment, potentially including agents suitable for facial and truncal acne, may help mitigate the substantial burden associated with acne.
Salari et al. (Fri,) studied this question.